IT1196913B - 6.7 SECOERGOLINE - Google Patents

6.7 SECOERGOLINE

Info

Publication number
IT1196913B
IT1196913B IT8022080A IT2208080A IT1196913B IT 1196913 B IT1196913 B IT 1196913B IT 8022080 A IT8022080 A IT 8022080A IT 2208080 A IT2208080 A IT 2208080A IT 1196913 B IT1196913 B IT 1196913B
Authority
IT
Italy
Prior art keywords
secoergoline
Prior art date
Application number
IT8022080A
Other languages
Italian (it)
Other versions
IT8022080A0 (en
Inventor
Aldemio Temperilli
Luigi Bernardi
Original Assignee
Erba Farmitalia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Farmitalia filed Critical Erba Farmitalia
Publication of IT8022080A0 publication Critical patent/IT8022080A0/en
Application granted granted Critical
Publication of IT1196913B publication Critical patent/IT1196913B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/90—Benzo [c, d] indoles; Hydrogenated benzo [c, d] indoles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
IT8022080A 1979-09-20 1980-05-15 6.7 SECOERGOLINE IT1196913B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7932589 1979-09-20

Publications (2)

Publication Number Publication Date
IT8022080A0 IT8022080A0 (en) 1980-05-15
IT1196913B true IT1196913B (en) 1988-11-25

Family

ID=10507944

Family Applications (1)

Application Number Title Priority Date Filing Date
IT8022080A IT1196913B (en) 1979-09-20 1980-05-15 6.7 SECOERGOLINE

Country Status (6)

Country Link
JP (1) JPS5646866A (en)
BE (1) BE883295A (en)
DE (1) DE3018514A1 (en)
FR (1) FR2465721A1 (en)
IT (1) IT1196913B (en)
NL (1) NL8002812A (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI76085C (en) * 1981-07-21 1988-09-09 Erba Farmitalia Process for the preparation of ergoline derivatives
JPH0737655Y2 (en) * 1989-02-06 1995-08-30 美津濃株式会社 Baseball / Softball protector
JPH08257197A (en) * 1995-03-06 1996-10-08 Paul Braithwal Brendon Protection means for sport player
CN115894519B (en) * 2022-10-21 2024-05-17 浙江大学 A tripeptide alkaloid compound and its preparation method and application

Also Published As

Publication number Publication date
IT8022080A0 (en) 1980-05-15
JPS5646866A (en) 1981-04-28
NL8002812A (en) 1981-03-24
BE883295A (en) 1980-09-01
DE3018514A1 (en) 1981-04-09
FR2465721A1 (en) 1981-03-27

Similar Documents

Publication Publication Date Title
NO161737C (en) 1,2,5-thiadiazole.
IT1209221B (en) IMPROVED MICROPOCESSOR.
DK537780A (en) 1,8-naphthyridin-DERIVATIVES
NO153847C (en) 2,4,4-trichloro-4-FORMYL-butyronitrile.
IT8025041A0 (en) ANTIBIOTIC U-59,761.
DK3881A (en) SUBSTITUTED 9,10-ANTHRACEN BISHYDRAZONS
SE8008339L (en) 24,24-DIFLUORO-1ALFA, 25-DIHYDROXIKOLEKALCIFEROL
NL7920160A (en) 24,24-DIFLUOR-25-HYDROXYCHOLECALCIFEROL.
FI803727A7 (en) 2,3-Indolidione derivatives.
IT7823796A0 (en) 1,2,4-TRIAZOLIDIN-3-ONI E-TIONI.
NO793494L (en) CYLINDERLAST I.
FI801473A7 (en) FRAMSTAELLNINGSFOERFARANDE FOER 5-MERKAPTO-1,2,3-TRIAZOLER
IT1196913B (en) 6.7 SECOERGOLINE
NL7901111A (en) 2,3-DIHYDRO-4H-1-BENZOPYRAN-4-ON-0-CARBAMOYLOXIMES.
FI800736A7 (en) 1,1'-diphenyl-2-ylalkylamine derivatives.
FI791080A7 (en) 4,6-dihalo-steroids.
IT1209140B (en) 6 ALFA-FLUORO-PREDNISOLONE 17,21-DIESTERI.
IT7925626A0 (en) 2,6-METHANO-3-BENZAZOCINE.
NL7803610A (en) 2,4,6-TRI-SUBSTITUTED 2,3-DIHYDROBENZOFURANS.
FI860774A0 (en) 3,4,5-TRIHYDROXIPIPERIDINDERIVAT.
DE2953592A1 (en) 24,24-DIFLUORO-25-HYDROXYCHOLECALCIFEROL
NO802405L (en) 2-sulfinyl-5-sulfonyl-1,3,4-THIADIAZOLDERIVATER
DK446582A (en) 24,24-difluoro-1alpha, 15-dihydro-5,6-TRANSCHOLECALCIFEROL
ES242227Y (en) IMPROVED VUGA.
ES243273Y (en) IMPROVED SILENTBLOC.